Skip to content


Nab-sirolimus, a protein-bound formulation, is a medication used in sarcoma therapy. It is administered intravenously (IV) and belongs to the class of mTOR inhibitors. Its therapeutic mechanism involves targeting the mTOR kinase pathway, which plays a pivotal role in cancer cell proliferation and survival. It is used to treat PEComa.